SIC
ARMP icon

Salem Investment Counselors’s Armata Pharmaceuticals ARMP Stock Holding History

Salem Investment Counselors’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$648 Hold
100
– – ﹤0.01% 1171
2026
Q1 		$1.02K Buy
+100
New +$842 ﹤0.01% 1128
2025
Q4 		– Sell
-100
Closed -$298 – 437
2025
Q3 		$298 Hold
100
– – ﹤0.01% 1179
2025
Q2 		$190 Hold
100
– – ﹤0.01% 1143
2025
Q1 		$146 Hold
100
– – ﹤0.01% 1193
2024
Q4 		$185 Hold
100
– – ﹤0.01% 1166
2024
Q3 		$237 Hold
100
– – ﹤0.01% 1158
2024
Q2 		$275 Hold
100
– – ﹤0.01% 1127
2024
Q1 		$418 Hold
100
– – ﹤0.01% 1124
2023
Q4 		$324 Hold
100
– – ﹤0.01% 1070
2023
Q3 		$300 Hold
100
– – ﹤0.01% 1061
2023
Q2 		$114 Hold
100
– – ﹤0.01% 1125
2023
Q1 		$167 Hold
100
– – ﹤0.01% 1082
2022
Q4 		$124 Hold
100
– – ﹤0.01% 1063
2022
Q3 		$0 Hold
100
– – ﹤0.01% 1033
2022
Q2 		$0 Hold
100
– – ﹤0.01% 1063
2022
Q1 		$0 Buy
+100
New +$512 ﹤0.01% 1000

Other funds holding ARMP

GWM
GSB Wealth Management Guilford, Connecticut $498M AUM 27.51% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CNBT
Cornerstone National Bank & Trust Palatine, Illinois $296M AUM 12.13% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Salem Investment Counselors's ARMP Position: Q2 2026 in Review

Salem Investment Counselors held its Armata Pharmaceuticals (ARMP) position steady in Q2 2026 at 100 shares worth $648. The position accounts for ﹤0.01% of the portfolio, ranked #1171.

Salem Investment Counselors first reported a position in ARMP in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.02K in Q1 2026. 6 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Salem Investment Counselors held 100 shares of Armata Pharmaceuticals worth $648 as of Q2 2026.
  • Salem Investment Counselors left its Armata Pharmaceuticals share count unchanged in Q2 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #1171 holding.
  • Salem Investment Counselors first reported a position in Armata Pharmaceuticals in Q1 2022 and has held it in 17 quarters since.
  • Salem Investment Counselors's Armata Pharmaceuticals position peaked at $1.02K in Q1 2026.
  • 6 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.